Examining the Genetic Predictors of Coronary Artery Calcification in African Americans
Predictors of Coronary Artery Calcification in an African American Cohort
3 other identifiers
observational
752
1 country
1
Brief Summary
Coronary artery disease (CAD) is an important health concern for African Americans, who are diagnosed with CAD at high rates. Coronary artery calcification, which is characterized by calcium deposits in the coronary arteries, is a contributing factor to CAD. This study will examine the possible genetic causes of coronary artery calcification in African Americans.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2009
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2009
CompletedFirst Submitted
Initial submission to the registry
June 19, 2009
CompletedFirst Posted
Study publicly available on registry
June 22, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2013
CompletedJune 19, 2013
June 1, 2013
4.2 years
June 19, 2009
June 18, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Coronary Artery Calcification
Measured during participants' single study visit
Study Arms (1)
No treatment
Eligibility Criteria
The study population will come from Jackson, MS and will include all men and women belonging to sibships that previously participated in the second GENOA exam. The sampling frame includes 1482 African Americans in 627 sibships providing 1552 sibling pairs from Jackson, Mississippi.
You may qualify if:
- Participated in the second GENOA exam in Jackson, Mississippi and is alive and willing to participate
You may not qualify if:
- Reported a history of heart attack, stroke, or coronary or non-coronary heart surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Michiganlead
- National Heart, Lung, and Blood Institute (NHLBI)collaborator
- University of Mississippi Medical Centercollaborator
- Wake Forest Universitycollaborator
- Mayo Cliniccollaborator
Study Sites (1)
University of Mississippi Medical Center
Jackson, Mississippi, 39216, United States
Biospecimen
Blood to measure risk factors and stored DNA for genetic studies
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Patricia Peyser, Ph.D.
University of Michigan
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Epidemiology
Study Record Dates
First Submitted
June 19, 2009
First Posted
June 22, 2009
Study Start
January 1, 2009
Primary Completion
April 1, 2013
Study Completion
April 1, 2013
Last Updated
June 19, 2013
Record last verified: 2013-06